Role of 5-lipoxygenase in the multiple organ failure induced by zymosan

Area of Science:

• Biochemistry
• Immunology
• Pathophysiology

Background:

• Multiple organ failure (MOF) is a critical condition often triggered by severe inflammation.
• The enzyme 5-lipoxygenase (5-LO) is implicated in inflammatory processes.
• Understanding the specific role of 5-LO in MOF pathogenesis is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the role of 5-lipoxygenase (5-LO) in the development of multiple organ failure (MOF) induced by zymosan.
• To evaluate the impact of 5-LO deficiency on inflammatory markers and tissue damage in a zymosan-induced MOF model.

Main Methods:

• Utilized 5-lipoxygenase gene-deficient (5-LOKO) mice and wild-type (WT) littermate controls.
• Induced MOF in mice via intraperitoneal injection of zymosan.
• Assessed MOF by monitoring body weight loss, mortality, histological damage, myeloperoxidase activity, lipid peroxidation, and expression of adhesion molecules (ICAM-1, P-selectin).

Main Results:

• Zymosan induced severe inflammation, lung and intestinal damage, increased neutrophil infiltration, and elevated lipid peroxidation in WT mice.
• 5-LO deficiency in mice significantly reduced peritoneal inflammation, tissue injury, neutrophil infiltration, and the expression of ICAM-1 and P-selectin in response to zymosan.
• Mice deficient in 5-LO exhibited significantly decreased mortality following zymosan administration.

Conclusions:

• 5-lipoxygenase (5-LO) plays a significant role in the pathogenesis of zymosan-induced multiple organ failure (MOF).
• Targeting 5-LO may represent a therapeutic strategy to mitigate the severity of nonseptic shock and associated organ damage.